The Valley Desk

NCT00419250 · Interventional trial

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

Overall registry status Completed

Phase 1

Conditions Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov